DOI:

Challenging TAVI anatomies, risk prediction for PCI of chronic total occlusions, antithrombotic strategies, and more

Davide Capodanno

It is a strange spring that is deprived of international interventional congresses. The COVID-19 pandemic is severely challenging multiple health systems around the world, and the effort of large and small countries to contain the infection is both admirable and generous. Unfortunately – and understandably – circumstances have led to a review of plans regarding many traditional events in the field of cardiology, such as CIT, TCTAP and ACC. A few years ago I wrote about the importance of foreseeing novel educational platforms when challenging scenarios are on the horizon1. Certainly, at that time, I could not have anticipated the day when an invisible enemy such as the coronavirus would change the plans of many cardiological organisations, and – more importantly – threaten the health of so many people worldwide, forcing entire populations to resort to an instrument of protection as old as quarantine. Waiting for the end of this emergency status, let’s dedicate ourselves to the only contagion we like – that of science and education. These are the hot topics in the electronic April issue of EuroIntervention.

The section on interventions for valvular disease and heart failure once again focuses on TAVI and its many procedural aspects. Firstly, the valve itself. Last year, the results of the SCOPE 1 trial were presented at TCT and simultaneously published in The Lancet2. TAVR with the self-expanding ACURATE neo did not meet non-inferiority compared to the balloon-expandable SAPIEN 3 device with respect to a composite of various early safety and clinical efficacy outcomes. Later this year, SCOPE 2 will assess the ACURATE neo bioprosthesis vis-à-vis another self-expanding bioprosthesis, with a hard primary clinical endpoint at 12 months. Meanwhile, we host a review article from Won-Keun Kim, Helge Möllmann and colleagues on clinical data and best practice for implantation of the ACURATE neo transcatheter valve. In another study from Riccardo Gorla, Francesco Bedogni and colleagues, the Portico and Evolut R valves were compared on the basis of paravalvular leak and device success in 107 TAVI patients with an elliptic aortic annulus. The results of this study may be of interest when deciding on the selection of a self-expanding bioprosthesis. In fact, it is well known that an elliptic geometry may lead to gaps between the aortic root and the prosthesis, which is designed to expand circularly, resulting in paravalvular leak. Another article from Satoshi Tsuchiya, Hiroaki Shimokawa and colleagues highlights the putative impact of TAVI on cerebral blood flow, cardiac output, and cognitive functions in elderly patients. Using paired data at baseline and three months, the results provide the first evidence that TAVI may improve cognitive functions associated with increased cerebral perfusion, especially in the hippocampus. The study is accompanied by an enlightening editorial by Rodrigo Bagur.

Let’s now review as usual the series of articles on coronary interventions. Following the results of the COMPLETE trial, it is now well accepted that patients with STEMI and multivessel disease should be offered complete revascularisation if they do not present with cardiogenic shock. Open questions, however, concern the timing of complete revascularisation and how non-culprit lesions should be identified (e.g., angiographically or physiologically, invasively or non-invasively). Francesco Maria Lauri, Javier Escaned and colleagues have elaborated on this topic by evaluating the diagnostic accuracy of quantitative flow ratio (QFR) for the functional assessment of non-culprit lesions during the acute phase of STEMI. The study is accompanied by an editorial from the principal investigator of the COMPLETE trial, Samir R. Mehta. Another STEMI study, from Mikkel M. Schoos, Thomas Engstrøm and colleagues, reports the comparative efficacy of bivalirudin or heparin in the subset of patients undergoing cardiac magnetic resonance in the DANAMI-3 trial (another trial of complete revascularisation in patients with multivessel disease and acute myocardial infarction). Also in this issue of EuroIntervention, the GLOBAL LEADERS investigators report on the impact of ticagrelor monotherapy in elderly patients undergoing PCI. Although the trial was formally neutral, the analysis was pre-specified and points towards the identification of meaningful subsets for the antiplatelet monotherapy strategy, to be further explored in future investigations conducted in PCI patients with stable coronary artery disease and/or acute coronary syndromes. In that respect, the results of this sub-analysis of GLOBAL LEADERS in the elderly are intriguing and hypothesis-generating. The study features an accompanying editorial from Guillaume Cayla. Let’s now move the spotlight to PCI for chronic total occlusions, with two studies that will attract the interest of both expert operators and beginners. The first study, from Wataru Nagamatsu, Osamu Katoh and colleagues, introduces a novel score model for predicting the success of collateral channel guidewire crossing during retrograde PCI. The score, developed by multivariate analysis with angiographic findings, promises to be quite useful to inform the appropriate selection of collateral channels. Also about prediction rules for PCI of chronic total occlusions, we publish another study from Andreas S. Kalogeropoulos, Grigoris V. Karamasis and colleagues, comparing the novel EuroCTO (CASTLE) score with the J-CTO score for predicting technical success. Interestingly, one score (I’ll let you discover which one) outperformed the other with respect to its discriminatory capacity for (more) complex cases. The study is complemented by the accompanying editorial of Emmanouil Brilakis and colleagues.

Can we leave our peripheral interventions enthusiasts without a new paper in this issue? Certainly not. In the randomised EffPac trial, reported by Ulf Teichgräber, Markus Thieme and colleagues, the safety and efficacy of the Luminor paclitaxel-nano-coated balloon were compared to those of an uncoated balloon catheter in inhibiting restenosis and ensuring long-term patency after 12 months.

This is what we have prepared for you in this electronic April issue. While we continue to foster strategies and new solutions to enhance your experience of the Journal, please do not hesitate to let us know your opinion and your suggestions, and reactions to what you read here, on the website or through social media.

Supplementary data

To read the full content of this article, please download the PDF.

Volume 15 Number 18
Apr 3, 2020
Volume 15 Number 18
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-E-24-00065 Apr 21, 2025
From invasive gradients to pressure recovery: rethinking long-standing paradigms
Joner M and Mylotte D
free

Editorial

10.4244/EIJ-E-25-00011 Apr 21, 2025
Transcatheter aortic valve implantation with complex, high-risk indicated PCI
Patterson T and McDonaugh B
free

Flashlight

10.4244/EIJ-D-24-00871 Apr 21, 2025
Management of bioprosthetic valve failure at 10 years after TAV-in-SAV
Jelisejevas J et al

Debate

10.4244/EIJ-E-24-00071 Apr 21, 2025
Could the age threshold for TAVI be relaxed to below 65 years? Pros and cons
Garot P et al

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
Trending articles
69.746

10.4244/EIJV13I12A217 Dec 8, 2017
Swimming against the tide: insights from the ORBITA trial
Al-Lamee R and Francis D
free
58.8

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
57.6

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
39.45

Clinical research

10.4244/EIJ-D-23-00725 Nov 19, 2023
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al
free
39.45

Original Research

10.4244/EIJ-D-23-00725 Mar 18, 2024
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al
free
38.75

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free
36

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
28.5

CLINICAL RESEARCH

10.4244/EIJV11I1A6 May 19, 2015
European expert consensus on rotational atherectomy
Barbato E et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved